Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02196168
Title Cisplatin With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

oral squamous cell carcinoma

hypopharynx cancer

laryngeal squamous cell carcinoma

paranasal sinus cancer

head and neck squamous cell carcinoma

oropharynx cancer

Therapies

Adavosertib

Cisplatin

Age Groups: adult
Covered Countries CAN


No variant requirements are available.